Alnylam Pharmaceuticals
ALNY
#1109
Rank
โ‚น2.005 T
Marketcap
โ‚น14,975
Share price
5.41%
Change (1 day)
-62.55%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company